Imatinib, olaparib, olaratumab and regorafenib are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications.
Added: Thursday 31 August 2017
Lenvatinib is now listed in the interaction checker as a cancer drug and interactions can be found with all the comedications.
Lenvatinib (Lenvima®, Kisplyx®) is a tyrosine kinase inhibitor and is indicated for the treatment of thyroid neoplasms and renal cell carcinoma.
Added: Tuesday 11 July 2017
Temsirolimus has been added to the interaction checker as a cancer drug and interactions are now listed with all the comedications.
Temsirolimus (Torisel®) is a mTOR inhibitor and is indicated for the treatment of mantle-cell lymphoma and renal cell carcinoma.
Added: Friday 30 June 2017
Welcome to this new website for drug interactions with anti-cancer agents. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology expertise of Radboud University Nijmegen (the Netherlands), the site will provide a world-leading DDI resource which will inform clinicians, pharmacists and patients abou...
Added: Thursday 01 June 2017